B1 Non-refereed article in a scientific journal

Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type?

Authors: Kimmo Kettunen, Peter Boström, Pekka Taimen

Publisher: ELSEVIER

Publication year: 2020

Journal:European Urology

Journal name in sourceEUROPEAN UROLOGY

Journal acronym: EUR UROL

Volume: 77

Issue: 1

First page : E23

Last page: E23

Number of pages: 1

ISSN: 0302-2838

eISSN: 1873-7560

DOI: https://doi.org/10.1016/j.eururo.2019.09.011